NCT01741493View on ClinicalTrials.gov

A Study in Healthy Adults and Adult Subjects With Rheumatoid Arthritis to Evaluate the Safety, Tolerability and Pharmacokinetics After Multiple Doses of ABT-494

PHASE1CompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Rheumatoid Arthritis
Interventions
DRUG

ABT-494

Oral administration of ABT-494 capsules

DRUG

Placebo

Oral administration of placebo capsules

DRUG

Tofacitinib

Oral administration

Trial Locations (5)

16635

Site Reference ID/Investigator# 95815, Duncansville

33136

Site Reference ID/Investigator# 95817, Miami

45255

Site Reference ID/Investigator# 95816, Cincinnati

78744

Site Reference ID/Investigator# 92153, Austin

84058

Site Reference ID/Investigator# 97177, Orem

All Listed Sponsors
lead

AbbVie (prior sponsor, Abbott)

INDUSTRY

NCT01741493 - A Study in Healthy Adults and Adult Subjects With Rheumatoid Arthritis to Evaluate the Safety, Tolerability and Pharmacokinetics After Multiple Doses of ABT-494 | Biotech Hunter | Biotech Hunter